Skip to main content
. Author manuscript; available in PMC: 2014 Aug 19.
Published in final edited form as: J Immunol Methods. 2013 Oct 9;0:91–98. doi: 10.1016/j.jim.2013.09.012

Fig. 3.

Fig. 3

Assay development to validation. This schematic diagram illustrates the steps necessary to validate an endpoint immunogenicity assay such as the A3R5 Neutralizing Antibody Assay.